Liver Dysfunction Clinical Trial
Official title:
Study of Hemodynamic Conditions Measured During Hepatectomy
Hepatocellular insufficiency is a dreaded complication after hepatectomy, since, if it is persistent, it leads to the death of the patient in the absence of liver transplantation. The preoperative evaluation aims in particular to estimate the risk of postoperative hepatocellular insufficiency so as to minimize or contraindicate high-risk patients. It has been shown that the flow of the portal vein is correlated with liver function, especially in the living donor and after portal embolization. More recently, the study of flow rates in the portal vein and the hepatic artery after transplantation has shown a correlation with the recovery of graft function. The hypothesis is that portal and arterial flow after hepatectomy can predict postoperative hepatocellular function.
Measurements of flow rates in the portal vein and the hepatic artery by different transit times are available thanks to the Medistim VeriQTM system that the investigators already use routinely in the context of liver transplantation when performing hepatectomies. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02754219 -
Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction
|
Phase 1 | |
| Terminated |
NCT01079104 -
Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units
|
N/A | |
| Recruiting |
NCT00553553 -
Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery
|
N/A | |
| Completed |
NCT03641872 -
A Validation Cohort for ACLF Diagnosis and Prognosis
|
||
| Not yet recruiting |
NCT05559242 -
Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients
|
Phase 1 | |
| Recruiting |
NCT02473601 -
Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis
|
Phase 2 | |
| Completed |
NCT01000337 -
Markers of Liver Apoptosis After Anesthesia With Sevoflurane or Propofol
|
N/A | |
| Completed |
NCT03155984 -
Optimizing HBV Management During Anti-CD20 Antibodies
|
||
| Recruiting |
NCT06126419 -
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
|
N/A | |
| Completed |
NCT03515980 -
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
|
Phase 1 | |
| Completed |
NCT01338714 -
The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function
|
Phase 3 | |
| Completed |
NCT02005744 -
A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function
|
Phase 1 | |
| Completed |
NCT01367522 -
Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function
|
Phase 1 | |
| Recruiting |
NCT03805139 -
Role of Ajwa Derived Polyphenols in Dyslipidaemias
|
N/A | |
| Enrolling by invitation |
NCT05082077 -
Global Utilization And Registry Database for Improved preservAtion of doNor Livers
|
||
| Completed |
NCT02949505 -
Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation
|
N/A | |
| Completed |
NCT02991339 -
The Effects of Dexamethasone Administration on Jaundice Following Liver Resection
|
Phase 2/Phase 3 | |
| Completed |
NCT02992639 -
Weight Loss Effect on Circulating Liver Enzymes
|
N/A | |
| Recruiting |
NCT05793203 -
Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients
|
||
| Recruiting |
NCT03519074 -
Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction
|
Phase 2 |